首页> 美国卫生研究院文献>other >Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents

【2h】

Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents

机译：暴露于Ga基造影剂的慢性肝病患者中肾源性系统纤维化的风险低

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

PurposeTo determine the risk of nephrogenic systemic fibrosis (NSF) in a cohort of patients with chronic liver disease.

机译：目的确定一组患有慢性肝病的患者的肾源性系统性纤维化（NSF）的风险。

著录项

期刊名称 other
作者
Emmanuil Smorodinsky; David S. Ansdell; Zeke W. Foster; Sameer M. Mazhar; Irene Cruite; Tanya Wolfson; Sebastian B. Sugay; Gabriella Iussich; Masoud Shiehmorteza; Yuko Kono; Alexander Kuo; Claude B. Sirlin;
展开▼
作者单位

展开▼
年(卷),期 -1(41),5
年度 -1
页码 1259–1267
总页数 20
原文格式 PDF
正文语种
中图分类
关键词
nephrogenic systemic fibrosis chronic liver disease;

机译：肾源性全身纤维化;慢性肝病;

相似文献

外文文献
中文文献
专利

1. Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents [J] . Smorodinsky Emmanuil, Ansdell David S., Foster Zeke W., Journal of magnetic resonance imaging: JMRI . 2015 ,第5期

机译：暴露于Ga基造影剂的慢性肝病患者中肾原性系统纤维化的风险低
2. Risk of Nephrogenic Systemic Fibrosis in Patients With Stage 4 or 5 Chronic Kidney Disease Receiving a Group II Gadolinium-Based Contrast Agent A Systematic Review and Meta-analysis [J] . Woolen Sean A., Shankar Prasad R., Gagnier Joel J., JAMA internal medicine . 2020 ,第2期

机译：患有第4阶段或5阶段慢性肾病患者肾上全身纤维化的风险接受II组钆的造影剂进行系统审查和荟萃分析
3. Application of gadolinium-based contrast agents and prevalence of nephrogenic systemic fibrosis in a cohort of end-stage renal disease patients on hemodialysis [J] . BeckerS., WalterS., WitzkeO., Nephron . 2012 ,第1a2期

机译：lin基造影剂在肾透析终末期患者血液透析中的应用和肾原性系统性纤维化的患病率
4. The Natural History of Chronic Kidney Disease Revisited-A 72-Month Mayo Health System Hypertension Clinic Practice-Based Research Network Prospective Report on End-Stage Renal Disease and Death Rates in 100 High-Risk Chronic Kidney Disease Patients: A Call for Circumspection [C] . Macaulay A.C. Onuigbo Conference on Peritoneal Dialysis . 2009

机译：慢性肾病的自然历史重新审议-A 72个月的MASO卫生系统高血压诊所的研究网络网络前期肾病和死亡率100个高危慢性肾病患者的死亡率：一个呼吁守则
5. Utilization patterns and economic impact of IV iron and erythropoiesis stimulating agents in chronic kidney disease patients: A multi-hospital study [D] . Joshi, Avani D. 2010

机译：慢性肾脏病患者静脉输注铁和促红细胞生成素刺激剂的使用模式和经济影响：一项多院研究
6. Gadolinium-based contrast agents erythropoietin and nephrogenic systemic fibrosis in patients with end-stage renal failure [O] . Herwig Pieringer, Sabine Schumacher, Bernhard Schmekal, 2008

机译：d基造影剂促红细胞生成素和肾源性全身纤维化在终末期肾衰竭患者中的作用
7. Risk of nephrogenic systemic fibrosis is low in patients with chronic liver disease exposed to gadolinium-based contrast agents [O] . Emmanuil Smorodinsky, David S. Ansdell, Zeke W. Foster, 2014

机译：慢性肝病暴露于基于Gadolinium的造影剂的患者肾肾上腺系统纤维化的风险较低

Risk of Nephrogenic Systemic Fibrosis Is Low in Patients With Chronic Liver Disease Exposed to Gadolinium-Based Contrast Agents

摘要

著录项

相似文献

相关主题

期刊订阅